Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT)
- PMID: 2372006
- DOI: 10.1093/oxfordjournals.aje.a115656
Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT)
Abstract
For men participating in the Multiple Risk Factor Intervention Trial, the authors evaluated the relation between the baseline forced expiratory volume in one second and lung cancer mortality among smokers between the third and tenth years of follow-up (1973-1974 to 1984). This measure of ventilatory function was a powerful predictor of lung cancer deaths, with rates that increased from 3.02 per 1,000 person-years in the lowest quintile of forced expiratory volume to 0.43 in the highest quintile. This relation was not weakened by adjustments for smoking dose, including number of cigarettes smoked per day, tar and nicotine content, duration of smoking, or age at onset of smoking. Nor was forced expiratory volume related to time between its determination and lung cancer death. If these observations can be verified in other studies, the forced expiratory volume in one second may identify smokers at very high risk of lung cancer and, hence, in need of more aggressive preventive approaches.
Similar articles
-
Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters.Int J Epidemiol. 2003 Aug;32(4):592-9. doi: 10.1093/ije/dyg177. Int J Epidemiol. 2003. PMID: 12913035 Clinical Trial.
-
Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.Cancer Epidemiol Biomarkers Prev. 1994 Jun;3(4):289-98. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8061576
-
The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT).Am J Public Health. 1990 Aug;80(8):954-8. doi: 10.2105/ajph.80.8.954. Am J Public Health. 1990. PMID: 2368857 Free PMC article. Clinical Trial.
-
The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardiovascular disease and FEV(1)--a review.Regul Toxicol Pharmacol. 2013 Dec;67(3):372-81. doi: 10.1016/j.yrtph.2013.08.016. Epub 2013 Sep 3. Regul Toxicol Pharmacol. 2013. PMID: 24013038 Review.
-
Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes.Eur Respir J. 2007 Oct;30(4):616-22. doi: 10.1183/09031936.00021707. Eur Respir J. 2007. PMID: 17906084 Review.
Cited by
-
Biomarkers of carcinogen exposure and cancer risk in a coke plant.Environ Health Perspect. 1993 Mar;99:237-9. doi: 10.1289/ehp.9399237. Environ Health Perspect. 1993. PMID: 8319632 Free PMC article.
-
Previous lung diseases and lung cancer risk: a systematic review and meta-analysis.PLoS One. 2011 Mar 31;6(3):e17479. doi: 10.1371/journal.pone.0017479. PLoS One. 2011. PMID: 21483846 Free PMC article.
-
Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.Oncotarget. 2016 Sep 13;7(37):59618-59629. doi: 10.18632/oncotarget.11162. Oncotarget. 2016. PMID: 27517752 Free PMC article.
-
Risk Factors for Cancer Mortality in Spain: Population-Based Cohort Study.Int J Environ Res Public Health. 2022 Aug 10;19(16):9852. doi: 10.3390/ijerph19169852. Int J Environ Res Public Health. 2022. PMID: 36011484 Free PMC article.
-
Chronic obstructive pulmonary disease and risk of lung cancer: a meta-analysis of prospective cohort studies.Oncotarget. 2017 Aug 18;8(44):78044-78056. doi: 10.18632/oncotarget.20351. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100446 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical